Latest News
A recently published study has suggested that certain anticholinergic medications, such as antidepressants and epilepsy drugs, may increase the risks of dementia later in life.
The first global report on epilepsy has been published by the WHO, which calls for action to make the condition a public health priority.
Researchers have identified the earliest signs of Parkinson’s disease in the brain, many years before patients show any symptoms.
Journal Articles
What is the optimal treatment for Duchenne muscular dystrophy in the MENA region? Find out in this paper published by Neurodegenerative Disease Management.
Jenny Straiton explores the miniature world of organoids and discusses how these small models are making big changes in the world of neurological research.
In this commentary from Future Neurology, the authors overview and compare cerebral organoids and other 3D aggregated cell cultures.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Hypertension drug increases cerebral blood flow in people with Alzheimer’s, study suggests
Regenerative stroke therapies: an interview with Steven Cramer
Stroke recovery: could the microbiome be a new therapeutic option?
CNS/PNS/SNS
New technology generates synthetic speech using brain activity
Cerebral organoids: scientists grow ‘mini-brains’ that can contract muscle
Cognitive/neurodegenerative disorders
Risk of dementia may be increased with certain anticholinergics, study suggests
Hypertension drug increases cerebral blood flow in people with Alzheimer’s, study suggests
Late-life Alzheimer’s pathology may be predicted with sleep history
Demyelinating disease
Multiple sclerosis: determining the dynamic nature of oligodendrocyte regeneration
Biomarker discovery and development in multiple sclerosis: where are we now?
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Development and pediatrics
Is exercise the newest way to re-tune brain structure in mice with autism spectrum disorder?
Autism linked to mutations in ‘junk’ DNA and not specific genes, study reveals
Brain organoids: defining maturity, addressing the challenges and exploring future directions
Epilepsy and seizure
WHO releases first global report on epilepsy
tRNAs: a blood-based biomarker for predicting seizures?
Children’s brains remap and retain visual perception after surgery for severe epilepsy
Genetics
Early-onset Alzheimer’s disease linked to high LDL cholesterol levels
Autism linked to mutations in ‘junk’ DNA and not specific genes, study reveals
Ask the Experts: Gene therapies in neurological diseases (Part II: challenges and future outlooks)
Headache
Why are migraines more common in women? New sex-specific insights revealed
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Alzheimer’s drug development halted following toxic reaction: industry news round-up
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
Could a bacterial polysaccharide suppress fatal brain inflammation?
Link between Alzheimer’s disease and periodontal bacteria gains traction
Injury/trauma
Could concussion symptoms in mice be reversed by magnetic therapy?
Tau biomarker linked to chronic traumatic encephalopathy in former athletes
New technology generates synthetic speech using brain activity
Movement disorders
Study reveals possible early signs of Parkinson’s in the brain
Stem cell therapies for Parkinson’s disease: current status and future perspectives
Could a noninvasive biomarker for Parkinson’s disease lie in EEG data?
Neuro-ophthalmology
Gene therapy breakthrough allows mice to regain sight
Could an eye scan detect signs of Alzheimer's disease?
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Addiction: a compulsive interplay between drugs, cues and habits
Galanin identified as new therapeutic target for the treatment of depression
Brain ‘fingerprinting’: a whole-system perspective into psychiatric conditions
Oncology/tumor
Depatux-M fails to meet primary endpoint in late-stage trial for newly diagnosed glioblastoma
CAR T-cell therapy: what are the neurological side effects?
SurVaxM for newly diagnosed glioblastoma: an interview with Manmeet Ahluwalia
Pain
Why are migraines more common in women? New sex-specific insights revealed
Could neuropathic pain be treated by modulation of immune cells?
New smartphone application could detect first signs of opioid overdose
Sleep
Late-life Alzheimer’s pathology may be predicted with sleep history
Can night owls ‘retrain’ their body clocks to improve mental wellbeing and performance?
